Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Concetta Quintarelli

Showing results (11-20 of 89) with videos related to

Pageof 9
Sort By:
Cancers|August 27, 2021
PI3K/Akt Pathway: The Indestructible Role of a Vintage Target as a Support to the Most Recent Immunotherapeutic ApproachesMatteo Caforio, Emmanuel de Billy, Biagio De Angelis, et al.
Immunology|August 16, 2022
The immune response as a double-edged sword: The lesson learnt during the COVID-19 pandemicChiara Agrati, Rita Carsetti, Veronica Bordoni, et al.
Journal of Clinical Medicine|October 19, 2019
NK Cell-Based Immunotherapy for Hematological MalignanciesSimona Sivori, Raffaella Meazza, Concetta Quintarelli, et al.
Scientific Reports|October 27, 2017
Combined immunotherapy with anti-PDL-1/PD-1 and anti-CD4 antibodies cures syngeneic disseminated neuroblastomaValentina Rigo, Laura Emionite, Antonio Daga, et al.
Radiology|April 9, 2014
Advanced-stage Hodgkin lymphoma: US/chest radiography for detection of relapse in patients in first complete remission--a randomized trial of routine surveillance imaging proceduresMarco Picardi, Novella Pugliese, Michele Cirillo, et al.
Journal of Materials Chemistry. B|February 19, 2020
Stimuli-responsive nanoparticle-assisted immunotherapy: a new weapon against solid tumoursBiagio De Angelis, Nicoletta Depalo, Francesca Petronella, et al.
Frontiers in Immunology|June 24, 2021
Innovative and Promising Strategies to Enhance Effectiveness of Immunotherapy for CNS Tumors: Where Are We?Concetta Quintarelli, Antonio Camera, Roselia Ciccone, et al.
Diagnostics (Basel, Switzerland)|January 21, 2022
Nanoparticles for Diagnosis and Target Therapy in Pediatric Brain CancersClara Guido, Clara Baldari, Gabriele Maiorano, et al.
Journal of Translational Medicine|April 25, 2019
Combinations of immuno-checkpoint inhibitors predictive biomarkers only marginally improve their individual accuracyMatteo Pallocca, Davide Angeli, Fabio Palombo, et al.
Blood|July 2, 2008
Cytotoxic T lymphocytes directed to the preferentially expressed antigen of melanoma (PRAME) target chronic myeloid leukemiaConcetta Quintarelli, Gianpietro Dotti, Biagio De Angelis, et al.
Pageof 9

Showing results (11-20 of 89) with videos related to

Sort By:
Pageof 9
Cancers|August 27, 2021
PI3K/Akt Pathway: The Indestructible Role of a Vintage Target as a Support to the Most Recent Immunotherapeutic ApproachesMatteo Caforio, Emmanuel de Billy, Biagio De Angelis, et al.
Immunology|August 16, 2022
The immune response as a double-edged sword: The lesson learnt during the COVID-19 pandemicChiara Agrati, Rita Carsetti, Veronica Bordoni, et al.
Journal of Clinical Medicine|October 19, 2019
NK Cell-Based Immunotherapy for Hematological MalignanciesSimona Sivori, Raffaella Meazza, Concetta Quintarelli, et al.
Scientific Reports|October 27, 2017
Combined immunotherapy with anti-PDL-1/PD-1 and anti-CD4 antibodies cures syngeneic disseminated neuroblastomaValentina Rigo, Laura Emionite, Antonio Daga, et al.
Radiology|April 9, 2014
Advanced-stage Hodgkin lymphoma: US/chest radiography for detection of relapse in patients in first complete remission--a randomized trial of routine surveillance imaging proceduresMarco Picardi, Novella Pugliese, Michele Cirillo, et al.
Journal of Materials Chemistry. B|February 19, 2020
Stimuli-responsive nanoparticle-assisted immunotherapy: a new weapon against solid tumoursBiagio De Angelis, Nicoletta Depalo, Francesca Petronella, et al.
Frontiers in Immunology|June 24, 2021
Innovative and Promising Strategies to Enhance Effectiveness of Immunotherapy for CNS Tumors: Where Are We?Concetta Quintarelli, Antonio Camera, Roselia Ciccone, et al.
Diagnostics (Basel, Switzerland)|January 21, 2022
Nanoparticles for Diagnosis and Target Therapy in Pediatric Brain CancersClara Guido, Clara Baldari, Gabriele Maiorano, et al.
Journal of Translational Medicine|April 25, 2019
Combinations of immuno-checkpoint inhibitors predictive biomarkers only marginally improve their individual accuracyMatteo Pallocca, Davide Angeli, Fabio Palombo, et al.
Blood|July 2, 2008
Cytotoxic T lymphocytes directed to the preferentially expressed antigen of melanoma (PRAME) target chronic myeloid leukemiaConcetta Quintarelli, Gianpietro Dotti, Biagio De Angelis, et al.
Pageof 9